Back to today’s briefing

Story perspectives

Senator Cassidy Urges Urgent Action on Mifepristone Safety

12/15/2025

28 5 Full Breakdown

Summary

Story summary

Senator Bill Cassidy (R-LA) said urgent action on healthcare and FDA safety studies for Mifepristone should be a White House priority.
He expressed impatience with the FDA's slow progress on safety studies for Mifepristone.
Cassidy proposed tax-free accounts to help patients cover high out-of-pocket costs.
He noted bipartisan interest and challenges in gaining Democratic support for a compromise that could improve healthcare affordability.

1 of 1

Story summary

Senator Bill Cassidy (R-LA) said urgent action on healthcare and FDA safety studies for Mifepristone should be a White House priority.
He expressed impatience with the FDA's slow progress on safety studies for Mifepristone.
Cassidy proposed tax-free accounts to help patients cover high out-of-pocket costs.
He noted bipartisan interest and challenges in gaining Democratic support for a compromise that could improve healthcare affordability.